FDA Guidance Document Supportive of Sarepta (SRPT) - William Blair
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.49 -0.01 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.50 | 52 Week High | $63.73 | |||
| Open | $17.39 | 52 Week Low | $8.00 | |||
| Day High | $17.55 | P/E | N/A | |||
| Day Low | $17.10 | EPS | $-5.69 | |||
| Volume | 2,198,641 | |||||
